QUOTE AND NEWS
Business Wire  Jan 11  Comment 
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare. The payment represents a milestone payment that recently
Business Wire  Jan 11  Comment 
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on January 7, 2010, it received notice from the Nasdaq Stock Market (Nasdaq) confirming that the Company has regained compliance with the $1.00 minimum closing
Business Wire  Nov 23  Comment 
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on November 19, 2009, the Company received notice from the Nasdaq Listing Qualifications Panel that it has regained compliance with the shareholders’ equity
Business Wire  Nov 16  Comment 
A.P. Pharma, Inc. (Nasdaq: APPA), a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2009. Results of Operations A.P. Pharma’s net loss for the third quarter 2009 was $1.2 million, or
StreetInsider.com  Sep 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/A.P.+Pharma+%28APPA%29+Announces+License+and+Development+Agreement+with+Merial/4943720.html for the full story.
StreetInsider.com  Jul 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/FDA+to+Review+A.P.+Pharma%27s+%28APPA%29+NDA+of+APF530+to+Treat+Chemotherapy-Induced+Nausea+and+Vomiting/4802987.html for the full story.
MarketWatch  Jul 20  Comment 
A.P. Pharma Inc. said Monday that it has received notice from the Nasdaq Stock Market that it has not regained compliance with a rule on minimum stockholders equity. The company said it intends to request a hearing at which it will present its...



Thank you for your suggestion


 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki